Is Minoxidil Still the Best Treatment for Hair Loss?

Minoxidil has been the gold standard for hair loss treatment for decades, but new research is challenging how we think about this solution and offering insights into what overall treatment approaches might work even better. Two significant studies emerging between 2025 and 2026 are reshaping the conversation around topical treatments, pointing to a future that is more targeted, more personalized, and potentially more effective.

Why does this matter now? Because the hair loss landscape is expanding quickly. Between peptides, PRP, laser therapy, and newer medications, there are more options than ever before. Understanding where minoxidil fits can help you make more informed, strategic decisions about your treatment approach.

What’s Minoxidil And Why It’s A Go-To Treatment

Minoxidil is often considered the benchmark in hair loss treatment. Originally developed as an oral medication for high blood pressure, doctors and patients noticed that it also helped stimulate hair growth, leading to its development as a topical treatment for people experiencing hair thinning or loss. Today, it’s widely available over the counter in 2% and 5% formulations and is typically applied once or twice daily.

It primarily works as a vasodilator, meaning it increases blood flow to the hair follicles. This improved circulation can help prolong the anagen (growth) phase of the hair cycle and may stimulate certain growth factors that support follicle activity.[1]

While minoxidil is very effective for many people, it does have limitations: It requires consistent, ongoing use to maintain results (which some people have trouble sticking with) and many users find that improvements plateau after about 12 to 16 months. And there can be side effects like scalp irritation, an initial increase in shedding, or unwanted facial hair growth; particularly in women.[2] Also, minoxidil doesn’t address the underlying causes of hair loss, such as hormonal shifts, inflammation, or nutritional deficiencies.

The Studies That Could Change How We Think About Treatment

Study #1: Peptide Serum vs. Minoxidil

For the first time, a randomized, triple-masked clinical trial (so neither participants, investigators, nor evaluators know who’s getting what), is directly comparing a peptide-based hair serum to 2% minoxidil. It’s designed to see if a peptide serum can perform as well as minoxidil.The study will include 80 participants with androgenetic alopecia over a 24-week period, with twice-daily application of either treatment.[3]

Researchers will measure outcomes like hair density, hair diameter, terminal hair count, patients’ experience using the treatments, and whether there are any side effects. Terminal hair count is particularly important; it refers to thicker, fully developed hairs, not the finer, shorter hairs often seen in early regrowth. In other words, it’s a meaningful indicator of true hair restoration.

What makes this study important is that it’s the first to directly compare a peptide-based topical to an established treatment, not just against placebo. While minoxidil works by increasing blood flow, peptide-based approaches aim to support the structural integrity of hair by targeting keratin production and follicle function.

There are still important unknowns. The trial hasn’t started (it’s expected to run through November 2026) and peptides are being compared to 2% minoxidil rather than the stronger 5% version, which may influence outcomes. And like most clinical trials, it’ll take time to understand long-term effectiveness and whether combining peptides with minoxidil could offer additive benefits. But still, since this study is comparing peptides head-to-head with a well-established, proven hair loss treatment, if the results are positive, it could be a major validation for peptide-based topicals as a clinically-validated option for androgenetic alopecia.

Study #2: Rethinking Minoxidil Through Better Delivery

Another line of research is focusing on improving how minoxidil works. A new study is exploring a biopolymer-based hydrogel designed to enhance the delivery of minoxidil into the scalp.[4]

One of the biggest challenges with topical treatments is how much actually gets absorbed and goes to where it needs to work efficiently. Topical treatments can sit on the surface of the scalp or are lost through evaporation or washing. This new hydrogel formulation is designed to improve penetration and retention, allowing more of the active ingredient to reach the follicle and stay there longer.

If successful, this approach could make existing concentrations more effective without increasing dosage. It may also reduce side effects, improve user experience, and even allow for less frequent application. Importantly, it could help explain why some people are considered “non-responders” to minoxidil; in some cases, the issue may be delivery, not the ingredient itself.

What This Means for Treatment Decisions

Taken together, these studies signal a meaningful shift in how we approach hair loss. More scientifically-supported treatment options are being studied and becoming available. Peptide-based treatments, along with other emerging therapies, offer different mechanisms that may be better suited to certain types of hair loss.

This also reflects a broader move toward personalization of hair loss treatments, which is an important shift that may lead to more effective options being available to a wide range of patients experiencing hair loss. Hair loss isn’t caused by a single factor, and the causes can be different for everyone; hair loss can be driven by hormones, nutritional deficiencies, stress, inflammation, circulation, or structural changes within the follicle.[5][6][7] Researchers and doctors are recognizing this and looking beyond one treatment effectively addressing all of the causes. Instead, the future lies in identifying each patient’s specific underlying causes and targeting them more precisely.

Minoxidil still plays an important role. It remains one of the most well-studied treatments available and can be particularly effective when circulation is a key factor. But it may work best as part of a multi-pronged approach rather than a standalone solution.

Regardless of the treatment you choose, consistency is crucial: Most topical therapies require at least three to six months before visible results appear, and combining treatments may offer better outcomes than relying on a single approach.

Questions to Ask Your Dermatologist

As treatment options become more nuanced, the conversation with your dermatologist matters. Hair loss isn’t a one-size-fits-all condition, and the most effective approach often depends on identifying what’s actually driving your shedding or thinning. Going into your appointment with a clear set of questions can help shift the discussion from simply choosing a product to building a more targeted, personalized treatment plan; one that may involve combining therapies or adjusting your approach over time.

• Am I a good candidate for Minoxidil based on my type of hair loss?

• Should I consider combination treatment (minoxidil + peptides, or minoxidil + prescription medication)?

• Would microneedling or other delivery enhancements improve my response?

• How do we measure whether it’s working, and when should we adjust our approach?

Why a Peptide Approach to Hair Growth Matters

As the science around hair loss evolves, one of the most interesting areas of innovation is peptides, and for good reason.

Peptides are short chains of amino acids that can be designed to “talk” to specific cells and processes in the body. When it comes to hair, that means working directly at the follicle level, where hair is actually formed. Peptides help support the structure and function of the hair itself, encouraging keratin production, stimulating follicle activity, and helping keep the growth cycle on track.[8] Because keratin is what gives hair its strength and resilience,[9] supplying the building blocks for your hair is a fundamentally different approach from treatments like Minoxidil.

This distinction is important. Many types of hair loss, particularly those linked to stress, hormonal changes, or metabolic shifts, involve disruptions in the hair growth cycle, inflammation, or reduced structural support within the follicle. A peptide-based approach is designed to address those deeper biological pathways.

Rather than taking a one-size-fits-all approach, peptide technologies can be tailored to target specific pathways involved in hair thinning, which opens the door to more targeted solutions, making peptides a compelling complement to existing treatments like minoxidil.

Which is why the conversation around hair loss treatments is evolving to explore how different approaches can work together. And increasingly, that means thinking beyond a single solution and toward a more comprehensive approach to hair health.

The Takeaway

Minoxidil isn’t going anywhere, but it’s not the whole story. As new research emerges, it’s becoming clear that hair loss is more complex than a single treatment can address. The future is about combining approaches that target different causes, from circulation to follicle structure to underlying biological triggers.

Frequently Asked Questions

Is Minoxidil still the most effective treatment for hair loss?

Minoxidil is still one of the most well-studied and effective options available, especially for people whose hair loss is linked to reduced blood flow to the follicles. But newer approaches, like peptide-based treatments, target different biological pathways, which means minoxidil may work best as part of a broader, combination strategy rather than on its own.

Why do some people not see results with minoxidil?

There are a few reasons. For some, it’s an issue of consistency; minoxidil needs to be used regularly for several months before results appear. For others, it may be a delivery problem, meaning the product isn’t penetrating the scalp effectively. And in some cases, the underlying cause of hair loss, like hormonal changes or stress, may not be addressed by the main way minoxidil works, which is focused on circulation.

How are peptides different from traditional hair loss treatments?

Peptides take a targeted, structural approach. They work at the follicle level to support keratin production, strengthen the hair as it forms, and help regulate the growth cycle. This makes them especially relevant for types of hair loss driven by stress, inflammation, or hormonal shifts, where the issue isn’t just circulation.

Can you use peptides and minoxidil together?

Potentially, yes. Because they work in different ways, peptides and minoxidil may complement each other. Minoxidil can help stimulate follicle activity through increased blood flow, while peptides support the structure and function of the hair itself. Research is still evolving, but combination approaches are becoming more common as we better understand the multiple factors involved in hair loss.